BPMC

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BPMC

<< 前へ 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/03/18	06 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/11	06 : 30	PR Newswire (US)	Blueprint Medicines to Showcase Scientific Leadership in Precision Oncology and Hematology at AACR Annual Meeting 2021	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/06	07 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/06	07 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/06	07 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/06	07 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/06	07 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/06	06 : 01	PR Newswire (US)	Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/04	06 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/04	06 : 28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/04	06 : 27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/04	06 : 27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/04	06 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/04	06 : 20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/04	06 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/04	06 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/03	22 : 00	PR Newswire (US)	Blueprint Medicines Announces EMA Validation of Type II Variation Marketing Authorization Application for AYVAKYT® (avapriti...	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/02/18	06 : 52	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/02/17	22 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/02/17	21 : 00	PR Newswire (US)	Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial Results	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/02/11	00 : 42	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/02/10	22 : 00	PR Newswire (US)	Blueprint Medicines to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 17, 2021	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/02/09	00 : 18	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/02/06	06 : 01	PR Newswire (US)	Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/02/04	04 : 15	Edgar (US Regulatory)	Schedule 13g	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/01/29	20 : 03	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/01/20	06 : 28	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/01/11	22 : 21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/01/11	22 : 05	PR Newswire (US)	Blueprint Medicines Announces R&D Leadership Transitions	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/01/11	22 : 00	PR Newswire (US)	Blueprint Medicines Reports Portfolio Milestones and Outlines 2021 Roadmap for Precision Medicine Leadership	NASDAQ:BPMC	Blueprint Medicines Corporation